Pulse Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLSE and other ETFs, options, and stocks.

About PLSE

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. 

CEO
Paul A. LaViolette
CEOPaul A. LaViolette
Employees
116
Employees116
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2014
Founded2014
Employees
116
Employees116

PLSE Key Statistics

Market cap
2.90B
Market cap2.90B
Price-Earnings ratio
-34.67
Price-Earnings ratio-34.67
Dividend yield
Dividend yield
Average volume
420.05K
Average volume420.05K
High today
$45.90
High today$45.90
Low today
$37.40
Low today$37.40
Open price
$38.34
Open price$38.34
Volume
545.22K
Volume545.22K
52 Week high
$45.90
52 Week high$45.90
52 Week low
$12.56
52 Week low$12.56

Stock Snapshot

The current Pulse Biosciences(PLSE) stock price is $41.28, with a market capitalization of 2.9B. The stock trades at a price-to-earnings (P/E) ratio of -34.67.

During the trading session on 2026-08-07, Pulse Biosciences(PLSE) shares reached a daily high of $45.90 and a low of $37.40. At a current price of $41.28, the stock is +10.4% higher than the low and still -10.1% under the high.

Trading activity shows a volume of 545.22K, compared to an average daily volume of 420.05K.

Over the past 52 weeks, Pulse Biosciences(PLSE) stock has traded between a high of $45.90 and a low of $12.56.

Over the past 52 weeks, Pulse Biosciences(PLSE) stock has traded between a high of $45.90 and a low of $12.56.

PLSE News

Investing.com 15h
Earnings call transcript: Pulse Biosciences misses Q2 2026 estimates but gains on trial progress - Investing.com

...

Earnings call transcript: Pulse Biosciences misses Q2 2026 estimates but gains on trial progress - Investing.com
TipRanks 21h
Pulse Biosciences Launches $75 Million ATM Equity Program

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 22h
Pulse Biosciences reports Q2 EPS (36c) vs (28c) last year

Reports Q2 revenue $400,000, consensus $533,330. “This was a highly productive quarter for Pulse Biosciences (PLSE), defined by exceptional momentum in our card...

More PLSE News

Simply Wall St 3d
Why Pulse Biosciences Is Up 6.4% After NANOPULSE-AF Trial Hits Enrollment Midpoint And What It Means

In July 2026, Pulse Biosciences, Inc. reported that its pivotal NANOPULSE-AF Study of the nPulse System for atrial fibrillation had passed the enrollment midpoi...

Why Pulse Biosciences Is Up 6.4% After NANOPULSE-AF Trial Hits Enrollment Midpoint And What It Means

People also own

Based on the portfolios of people who own PLSE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.